Jared Barsky
Examiner (ID: 13656, Phone: (571)272-2795 , Office: P/1628 )
Most Active Art Unit | 1628 |
Art Unit(s) | 1628 |
Total Applications | 964 |
Issued Applications | 443 |
Pending Applications | 93 |
Abandoned Applications | 428 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16288939
[patent_doc_number] => 10765762
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Humanized model of kidney and liver disorders
[patent_app_type] => utility
[patent_app_number] => 15/904808
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 53
[patent_no_of_words] => 22842
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15904808
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/904808 | Humanized model of kidney and liver disorders | Feb 25, 2018 | Issued |
Array
(
[id] => 13835621
[patent_doc_number] => 20190021295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => COMMON LIGHT CHAIN MOUSE
[patent_app_type] => utility
[patent_app_number] => 15/891987
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15891987
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/891987 | COMMON LIGHT CHAIN MOUSE | Feb 7, 2018 | Abandoned |
Array
(
[id] => 12728809
[patent_doc_number] => 20180134770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => ANTIBODY PRODUCING NON-HUMAN ANIMALS
[patent_app_type] => utility
[patent_app_number] => 15/870621
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870621
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/870621 | Antibody producing non-human animals | Jan 11, 2018 | Issued |
Array
(
[id] => 12728809
[patent_doc_number] => 20180134770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => ANTIBODY PRODUCING NON-HUMAN ANIMALS
[patent_app_type] => utility
[patent_app_number] => 15/870621
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870621
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/870621 | Antibody producing non-human animals | Jan 11, 2018 | Issued |
Array
(
[id] => 12728809
[patent_doc_number] => 20180134770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => ANTIBODY PRODUCING NON-HUMAN ANIMALS
[patent_app_type] => utility
[patent_app_number] => 15/870621
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870621
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/870621 | Antibody producing non-human animals | Jan 11, 2018 | Issued |
Array
(
[id] => 12750517
[patent_doc_number] => 20180142006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => ANTIBODY PRODUCING NON-HUMAN ANIMALS
[patent_app_type] => utility
[patent_app_number] => 15/870663
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22811
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870663
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/870663 | ANTIBODY PRODUCING NON-HUMAN ANIMALS | Jan 11, 2018 | Abandoned |
Array
(
[id] => 12728809
[patent_doc_number] => 20180134770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => ANTIBODY PRODUCING NON-HUMAN ANIMALS
[patent_app_type] => utility
[patent_app_number] => 15/870621
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870621
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/870621 | Antibody producing non-human animals | Jan 11, 2018 | Issued |
Array
(
[id] => 12744316
[patent_doc_number] => 20180139939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => Nucleic Acid Construct with a p16 Promoter that Causes a Prodrug Converting Enzyme to be Expressed Specifically in Senescent Cells
[patent_app_type] => utility
[patent_app_number] => 15/870172
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16573
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870172
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/870172 | Nucleic acid construct with a p16 promoter that causes a prodrug converting enzyme to be expressed specifically in senescent cells | Jan 11, 2018 | Issued |
Array
(
[id] => 12750514
[patent_doc_number] => 20180142005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => ANTIBODY PRODUCING NON-HUMAN ANIMALS
[patent_app_type] => utility
[patent_app_number] => 15/870647
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870647
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/870647 | ANTIBODY PRODUCING NON-HUMAN ANIMALS | Jan 11, 2018 | Abandoned |
Array
(
[id] => 12750511
[patent_doc_number] => 20180142004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => ANTIBODY PRODUCING NON-HUMAN ANIMALS
[patent_app_type] => utility
[patent_app_number] => 15/868885
[patent_app_country] => US
[patent_app_date] => 2018-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15868885
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/868885 | Antibody producing non-human animals | Jan 10, 2018 | Issued |
Array
(
[id] => 13941273
[patent_doc_number] => 10206379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-19
[patent_title] => Non-human animals having a humanized signal-regulatory protein gene
[patent_app_type] => utility
[patent_app_number] => 15/866632
[patent_app_country] => US
[patent_app_date] => 2018-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16780
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15866632
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/866632 | Non-human animals having a humanized signal-regulatory protein gene | Jan 9, 2018 | Issued |
Array
(
[id] => 12750508
[patent_doc_number] => 20180142003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => ANTIBODY PRODUCING NON-HUMAN ANIMALS
[patent_app_type] => utility
[patent_app_number] => 15/866374
[patent_app_country] => US
[patent_app_date] => 2018-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 246
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15866374
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/866374 | ANTIBODY PRODUCING NON-HUMAN ANIMALS | Jan 8, 2018 | Pending |
Array
(
[id] => 12750505
[patent_doc_number] => 20180142002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => ANTIBODY PRODUCING NON-HUMAN ANIMALS
[patent_app_type] => utility
[patent_app_number] => 15/863787
[patent_app_country] => US
[patent_app_date] => 2018-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15863787
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/863787 | Antibody producing non-human animals | Jan 4, 2018 | Issued |
Array
(
[id] => 13339847
[patent_doc_number] => 20180221463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => Modified NK Cells and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 15/863159
[patent_app_country] => US
[patent_app_date] => 2018-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12878
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15863159
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/863159 | Modified NK Cells and Uses Thereof | Jan 4, 2018 | Abandoned |
Array
(
[id] => 15178851
[patent_doc_number] => 20190360017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => RECOMBINANT PROTEIN PRODUCTION SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/471229
[patent_app_country] => US
[patent_app_date] => 2017-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471229
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471229 | Recombinant protein production system | Dec 21, 2017 | Issued |
Array
(
[id] => 15432417
[patent_doc_number] => 20200030391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => VIRUS AAV/IGF2, GENETIC TREATMENT METHOD AND USE THEREOF IN PROTEIN MISFOLDING-RELATED DISEASES, SUCH AS HUNTINGTON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/472794
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12036
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472794
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/472794 | VIRUS AAV/IGF2, GENETIC TREATMENT METHOD AND USE THEREOF IN PROTEIN MISFOLDING-RELATED DISEASES, SUCH AS HUNTINGTON'S DISEASE | Dec 20, 2017 | Pending |
Array
(
[id] => 14360201
[patent_doc_number] => 10301388
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Antibody agents specific for human CD19 and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/840870
[patent_app_country] => US
[patent_app_date] => 2017-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 36
[patent_no_of_words] => 57626
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15840870
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/840870 | Antibody agents specific for human CD19 and uses thereof | Dec 12, 2017 | Issued |
Array
(
[id] => 15204351
[patent_doc_number] => 20190364862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => DMD REPORTER MODELS CONTAINING HUMANIZED DUCHENNE MUSCULAR DYSTROPHY MUTATIONS
[patent_app_type] => utility
[patent_app_number] => 16/467445
[patent_app_country] => US
[patent_app_date] => 2017-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -73
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467445
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467445 | DMD REPORTER MODELS CONTAINING HUMANIZED DUCHENNE MUSCULAR DYSTROPHY MUTATIONS | Dec 7, 2017 | Abandoned |
Array
(
[id] => 12546351
[patent_doc_number] => 10011658
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-03
[patent_title] => Constructs targeting AFP peptide/MHC complexes and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/829783
[patent_app_country] => US
[patent_app_date] => 2017-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 29
[patent_no_of_words] => 81376
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15829783
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/829783 | Constructs targeting AFP peptide/MHC complexes and uses thereof | Nov 30, 2017 | Issued |
Array
(
[id] => 12724417
[patent_doc_number] => 20180133306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => IMMUNIZATION OF AVIANS BY ADMINISTRATION OF NON-REPLICATING VECTORED VACCINES
[patent_app_type] => utility
[patent_app_number] => 15/824230
[patent_app_country] => US
[patent_app_date] => 2017-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15824230
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/824230 | Immunization of avians by administration of non-replicating vectored vaccines | Nov 27, 2017 | Issued |